Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm G Hanratty

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
American Heart Journal|November 21, 2022
Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery: Rationale and design of the multicenter, randomized PROCTOR trialRuben W de Winter, Simon J Walsh, Colm G Hanratty, et al.
The Journal of Invasive Cardiology|November 16, 2017
One-Year Clinical Outcomes of the Hybrid CTO Revascularization Strategy After Hospital Discharge: A Subanalysis of the Multicenter RECHARGE RegistryJoren Maeremans, Alexandre Avran, Simon Walsh, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 4, 2020
Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudyAndrew Ladwiniec, Simon J Walsh, Niels Ramsing Holm, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2018
Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation StudySimon J Walsh, Colm G Hanratty, Stuart Watkins, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trialRobert-Jan van Geuns, Chang Chun-Chin, Margaret B McEntegart, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 1, 2017
Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular functionWijnand J Stuijfzand, P Stefan Biesbroek, Pieter G Raijmakers, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 4, 2025
Biodegradable-polymer versus durable-polymer drug-eluting stents in left main percutaneous coronary intervention: final results of the randomised IDEAL-LM trialAlexander M Griffioen, Robert-Jan M van Geuns, Margaret B McEntegart, et al.
Journal of the American College of Cardiology|October 30, 2016
The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe: The RECHARGE RegistryJoren Maeremans, Simon Walsh, Paul Knaapen, et al.
Circulation. Cardiovascular Interventions|August 31, 2017
Fully Transradial Versus Transfemoral Approach for Percutaneous Intervention of Coronary Chronic Total Occlusions Applying the Hybrid Algorithm: Insights From RECHARGE RegistryErik Jan Bakker, Joren Maeremans, Carlo Zivelonghi, et al.
Circulation|August 10, 2022
Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 TrialRodney H Stables, Liam J Mullen, Mostafa Elguindy, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
American Heart Journal|November 21, 2022
Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery: Rationale and design of the multicenter, randomized PROCTOR trialRuben W de Winter, Simon J Walsh, Colm G Hanratty, et al.
The Journal of Invasive Cardiology|November 16, 2017
One-Year Clinical Outcomes of the Hybrid CTO Revascularization Strategy After Hospital Discharge: A Subanalysis of the Multicenter RECHARGE RegistryJoren Maeremans, Alexandre Avran, Simon Walsh, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 4, 2020
Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudyAndrew Ladwiniec, Simon J Walsh, Niels Ramsing Holm, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2018
Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation StudySimon J Walsh, Colm G Hanratty, Stuart Watkins, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trialRobert-Jan van Geuns, Chang Chun-Chin, Margaret B McEntegart, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 1, 2017
Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular functionWijnand J Stuijfzand, P Stefan Biesbroek, Pieter G Raijmakers, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 4, 2025
Biodegradable-polymer versus durable-polymer drug-eluting stents in left main percutaneous coronary intervention: final results of the randomised IDEAL-LM trialAlexander M Griffioen, Robert-Jan M van Geuns, Margaret B McEntegart, et al.
Journal of the American College of Cardiology|October 30, 2016
The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe: The RECHARGE RegistryJoren Maeremans, Simon Walsh, Paul Knaapen, et al.
Circulation. Cardiovascular Interventions|August 31, 2017
Fully Transradial Versus Transfemoral Approach for Percutaneous Intervention of Coronary Chronic Total Occlusions Applying the Hybrid Algorithm: Insights From RECHARGE RegistryErik Jan Bakker, Joren Maeremans, Carlo Zivelonghi, et al.
Circulation|August 10, 2022
Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 TrialRodney H Stables, Liam J Mullen, Mostafa Elguindy, et al.
Pageof 7